Medical research

Engineered T cells for type 1 diabetes move closer to clinic

For much of the last decade, Dr. David Rawlings, director of Seattle Children's Research Institute's Center for Immunity and Immunotherapies, has dreamed of developing a therapy for children with type 1 diabetes that doesn't ...

Immunology

Double-stranded RNA induces bone loss during gum disease

Tokyo University of Agriculture and Technology researchers reported on a new discovery regarding the mechanisms for bone loss in gum disease (periodontitis). They found that double stranded RNA molecules can activate the ...

Immunology

Breakthrough may explain why cancer immunotherapies can backfire

Research by University of Alberta scientists into PD-1, a cell surface receptor that naturally plays a major role in de-escalating the body's immune system, may explain why it can go haywire and cause autoimmune diseases ...

Oncology & Cancer

Terpenes inhibit liver cancer

As main component of essential oils, terpenes can inhibit the growth of different cancer cells. Researchers from the Ruhr-University Bochum headed by Prof Dr Dr Dr Hanns Hatt have analysed this process in liver cancer cells ...

Diseases, Conditions, Syndromes

What is the ACE2 receptor, and how is it connected to coronavirus?

In the search for treatments for COVID-19, many researchers are focusing their attention on a specific protein that allows the virus to infect human cells. Called the angiotensin-converting enzyme 2, or ACE2 "receptor," the ...

Neuroscience

Team discovers one more piece to the autism puzzle

Mutations in a subunit of a receptor that binds the major inhibitory neurotransmitter GABAA in the brain have been linked, through a common mechanism, to epilepsy, autism and intellectual disability, researchers at Vanderbilt ...

page 7 from 40